Sai Parenterals logo

Sai Parenterals financials and balance sheet

NSE: SAIPARENTBSE: 544742Pharmaceuticals & BiotechnologySmall Cap

Last close ₹461.70up ₹10.20 (2.26%)BSE ₹462.55

Share price at the NSE close on 23 Oct 2026. Previous close ₹451.50.

Range of traded prices from listing on 2 Apr 2026 to 23 Oct 2026
₹400.00Low, 2 Apr 2026₹706.00High, 2 Jul 2026
Market cap
₹2,040 Cr1,118th largest listed
P/E
No full year
P/B
4.2
Dividend yield
Nonesince listing in Apr 2026
Debt to equity
0.65
Volume, NSE
3,20,04060.5% delivered

1 year at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Sai Parenterals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue381
  2. Materials and goods−242
  3. Employee costs−29
  4. Other expenses−71
  5. Operating profit39
  6. Depreciation−17
  7. Other income+8.5
  8. One-off items0.0
  9. Finance costs−18
  10. Profit before tax12
  11. Tax+2.3
  12. Net profit14

What the company owns

  • Plant, investments and other assets₹654 Cr
  • Cash and bank₹417 Cr
  • Receivables₹181 Cr
  • Inventory₹172 Cr

What pays for it: net worth and liabilities

  • Net worth₹495 Cr
  • Other liabilities₹461 Cr
  • Borrowings₹319 Cr
  • Owed to suppliers₹149 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Sai Parenterals quarterly results

₹ croreMar 2026Filed 23 May
Revenue from operations381
342
Materials and goods bought242
Employee costs29
Other expenses71
Operating profit before depreciation39
Operating margin10.2%
Materials, % of revenue63.6%
Employee costs, % of revenue7.7%
Other expenses, % of revenue18.6%
Depreciation and amortisation17
Operating profit after depreciation22
Other income9
Finance costs18
One-off items0
Profit before tax12
−2
Net profit14
Other comprehensive income0
Total comprehensive income14
Net margin3.7%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2026Filed 23 May
495
491
Share capital22
Reserves469
Belonging to outside owners of subsidiaries4
319
573
356
Total assets1,424
602
822
Net debt−97
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2026Filed 23 May
93
98
56
Receivables−54
Inventories−121
Payables91
Other working capital140
Tax paid−5
Capital spending18
Free cash flow75
−274
596
Dividends paid0
Shares bought back0
Shares issued253
Net change in cash415
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2026Filed 23 May
Earnings per share₹4.36
Diluted earnings per share₹4.36
Book value per share₹111.09

Ratios

Consolidated, years to March.Sai Parenterals PE ratio and valuation

RatioMar 2026Filed 23 May
Return on equity2.9%
Return on capital employed2.7%
Cash conversion652.6%
Interest cover1.2
Debt to equity0.65
Receivable days173
Inventory days259
Payable days224
Cash conversion cycle, days208
Working capital days59
Asset turnover0.27
Assets per rupee of net worth2.90
Sales per rupee of plant6.18
Capital spending to depreciation1.08
Plant being built, % of plant in use344.4%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
1.0%
Cash from operations against operating profit
240.5%

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations93
Cash from investing−274
Cash from financing596
Capital spending18
Dividends paid0
Shares bought back0
Shares issued for cash253
Borrowings raised226
Borrowings repaid0

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2026
Effective tax ratePublished threshold 17.16 per cent−19.54
Tax charged less tax paid, % of profitOur threshold 10 percentage points−60.91
A threshold marked as ours has no published figure; it is the line we read the check against.